Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
000075.KS
Financial details
Company Rating
Strong Buy
Market Cap
481.88B
Income
160.21B
Revenue
3306.54B
Book val./share
21947.99
Cash/share
-
Dividend
3050
Dividend %
5.18%
Employees
449
Optionable
No
Shortable
Yes
Earnings
-
P/E
29.6
Forward P/E
-
PEG
-18.06
P/S
1.43
P/B
2.68
P/C
-
P/FCF
-426.56
Quick Ratio
-
Current Ratio
2.36
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.05K
EPS next Y
-
EPS next Q
-
EPS this Y
132.34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
44.52%
Revenue last 5Y
5.33%
Revenue Q/Q
4.93%
EPS Q/Q
-34.02%
-
-
-
-
SMA20
-1.23%
SMA50
-1.56%
SMA100
-8.65%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
9%
ROC
0.07%
Gross Margin
20%
Oper. Margin
8%
Profit Margin
5%
Payout
153%
Shs Outstand
303.97K
Shs Float
3.98M
-
-
-
-
Target Price
-
52W Range
56700.0-72800.0
52W High
-19.09%
52W Low
+3.88%
RSI
47.16
Rel Volume
0.43
Avg Volume
56
Volume
24
Perf Week
-0.17%
Perf Month
-2.48%
Perf Quarter
-6.06%
Perf Half Y
-5.31%
-
-
-
-
Beta
1.2246
-
-
Volatility
775.91%, 636.18%
Prev Close
-0.34%
Price
58900
Change
-0.51%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 322.43K | 344.89K | 334.77K | 332.35K | 401.47K | |
| Net income per share | 5.07K | 9.41K | 4.15K | 13.76K | 30.71K | |
| Operating cash flow per share | -2.94K | 11.77K | 29.45K | 33.02K | 31.19K | |
| Free cash flow per share | -14.7K | -9.61K | 8.1K | 11.41K | 5.14K | |
| Cash per share | 74.02K | 55.94K | 86.75K | 107.25K | 97.18K | |
| Book value per share | 184.81K | 189.92K | 190.97K | 204.38K | 226.3K | |
| Tangible book value per share | 222.96K | 231.78K | 235.97K | 253.88K | 266.66K | |
| Share holders equity per share | 184.81K | 189.92K | 190.97K | 204.38K | 226.3K | |
| Interest debt per share | 113.76K | 108.04K | 143.78K | 160.04K | 171.48K | |
| Market cap | 463.01B | 357.51B | 305.9B | 422.34B | 506.96B | |
| Enterprise value | 1185.52B | 1032.82B | 1181.48B | 1395.84B | 1631.75B | |
| P/E ratio | 12.29 | 5.11 | 9.91 | 4.13 | 2.13 | |
| Price to sales ratio | 0.19 | 0.14 | 0.12 | 0.17 | 0.16 | |
| POCF ratio | -21.16 | 4.09 | 1.4 | 1.72 | 2.1 | |
| PFCF ratio | -4.24 | -5 | 5.08 | 4.98 | 12.74 | |
| P/B Ratio | 0.34 | 0.25 | 0.22 | 0.28 | 0.29 | |
| PTB ratio | 0.34 | 0.25 | 0.22 | 0.28 | 0.29 | |
| EV to sales | 0.49 | 0.4 | 0.47 | 0.56 | 0.53 | |
| Enterprise value over EBITDA | 7.37 | 5.21 | 6.85 | 5.54 | 3.82 | |
| EV to operating cash flow | -54.18 | 11.81 | 5.4 | 5.69 | 6.76 | |
| EV to free cash flow | -10.85 | -14.45 | 19.62 | 16.46 | 41.01 | |
| Earnings yield | 0.08 | 0.2 | 0.1 | 0.24 | 0.47 | |
| Free cash flow yield | -0.24 | -0.2 | 0.2 | 0.2 | 0.08 | |
| Debt to equity | 0.46 | 0.36 | 0.62 | 0.59 | 0.44 | |
| Debt to assets | 0.41 | 0.4 | 0.43 | 0.45 | 0.46 | |
| Net debt to EBITDA | 4.49 | 3.41 | 5.07 | 3.87 | 2.63 | |
| Current ratio | 2.08 | 1.61 | 2.39 | 2.16 | 1.65 | |
| Interest coverage | 4.04 | 5.67 | 2.56 | 5.9 | 13.22 | |
| Income quality | -0.58 | 1.25 | 7.09 | 2.4 | 1.02 | |
| Dividend Yield | 0.05 | 0.06 | 0.08 | 0.06 | 0.06 | |
| Payout ratio | 0.56 | 0.3 | 0.82 | 0.25 | 0.12 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | |
| Capex to operating cash flow | 3.99 | -1.82 | -0.73 | -0.65 | -0.84 | |
| Capex to revenue | -0.04 | -0.06 | -0.06 | -0.07 | -0.06 | |
| Capex to depreciation | -1.14 | -2.06 | -1.73 | -1.72 | -2.19 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 145.19K | 200.57K | 133.59K | 251.55K | 395.44K | |
| ROIC | 0.04 | 0.05 | 0.03 | 0.05 | 0.1 | |
| Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.03 | 0.06 | |
| Graham Net | -85.99K | -97.84K | -102.48K | -104.1K | -133.43K | |
| Working capital | 588.28B | 400.74B | 732.35B | 793.87B | 648.26B | |
| Tangible asset value | 1657.06B | 1722.73B | 1754.09B | 1887.7B | 2063.92B | |
| Net current asset value | -198.92B | -254.62B | -300.53B | -261.86B | -384.15B | |
| Invested capital | 0.6 | 0.55 | 0.73 | 0.76 | 0.74 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 191.55B | 192.44B | 182.34B | 188.3B | 208.19B | |
| Average inventory | 308.11B | 335.14B | 319.68B | 332.6B | 416.56B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 36 | 34.48 | 31.79 | 35.22 | 35 | |
| Days of inventory on hand | 52.42 | 59.22 | 55.29 | 62.22 | 76.82 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 10.14 | 10.59 | 11.48 | 10.36 | 10.43 | |
| Inventory turnover | 6.96 | 6.16 | 6.6 | 5.87 | 4.75 | |
| ROE | 0.03 | 0.05 | 0.02 | 0.07 | 0.14 | |
| Capex per share | -11.76K | -21.38K | -21.35K | -21.61K | -26.05K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 101.45K | 106.13K | 9.94K | 10.21K | 10.72K | |
| Net income per share | 9.11K | 10.03K | 181.16 | 509.03 | 335.84 | |
| Operating cash flow per share | 12.7K | 8.28K | 727.62 | -235.1 | 748.11 | |
| Free cash flow per share | 5.91K | 3.28K | 102.66 | -848.48 | 292.18 | |
| Cash per share | 106.92K | 102.23K | 9.34K | 0 | 0 | |
| Book value per share | 217.92K | 231.82K | 21.76K | 22.07K | 21.95K | |
| Tangible book value per share | 264.08K | 278.7K | 25.63K | 30.9K | 30.69K | |
| Share holders equity per share | 217.92K | 231.82K | 21.76K | 22.07K | 21.95K | |
| Interest debt per share | 165.51K | 158.36K | 16.24K | 211.75 | 59.4 | |
| Market cap | 579.75B | 537.12B | 5555.39B | 5104.52B | 4726.11B | |
| Enterprise value | 1637.19B | 1581.45B | 6680.17B | 5104.52B | 4726.11B | |
| P/E ratio | 2.06 | 1.73 | 95.22 | 31.14 | 43.7 | |
| Price to sales ratio | 0.74 | 0.65 | 6.94 | 6.21 | 5.48 | |
| POCF ratio | 5.9 | 8.38 | 94.83 | -269.68 | 78.46 | |
| PFCF ratio | 12.68 | 21.14 | 672.12 | -74.72 | 200.9 | |
| P/B Ratio | 0.34 | 0.3 | 3.17 | 2.87 | 2.67 | |
| PTB ratio | 0.34 | 0.3 | 3.17 | 2.87 | 2.67 | |
| EV to sales | 2.08 | 1.93 | 8.35 | 6.21 | 5.48 | |
| Enterprise value over EBITDA | 14.62 | 13.62 | 193.35 | 68.8 | 123.44 | |
| EV to operating cash flow | 16.66 | 24.68 | 114.03 | -269.68 | 78.46 | |
| EV to free cash flow | 35.8 | 62.25 | 808.21 | -74.72 | 200.9 | |
| Earnings yield | 0.12 | 0.14 | 0 | 0.01 | 0.01 | |
| Free cash flow yield | 0.08 | 0.05 | 0 | -0.01 | 0 | |
| Debt to equity | 0.42 | 0.39 | 0.44 | 0 | 0 | |
| Debt to assets | 0.45 | 0.43 | 0.46 | 0.46 | 0.45 | |
| Net debt to EBITDA | 9.44 | 8.99 | 32.56 | 0 | 0 | |
| Current ratio | 1.62 | 1.72 | 1.65 | 2.16 | 2.36 | |
| Interest coverage | 17.52 | 18.87 | 4.74 | 2.9 | 10.65 | |
| Income quality | 1.39 | 0.83 | 4.02 | -0.46 | 2.23 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0 | 0 | 0 | 0.12 | 1.07 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.12 | 0.12 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.02 | 0 | 0 | |
| Intangibles to total assets | 0.06 | 0.07 | 0.08 | 0 | 0 | |
| Capex to operating cash flow | -0.53 | -0.6 | -0.86 | 2.61 | -0.61 | |
| Capex to revenue | -0.07 | -0.05 | -0.06 | -0.06 | -0.04 | |
| Capex to depreciation | -8.5 | -6.33 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 211.31K | 228.68K | 9.42K | 15.9K | 12.88K | |
| ROIC | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | |
| Return on tangible assets | 0.02 | 0.02 | 0 | 0.01 | 0.01 | |
| Graham Net | -111.78K | -110.89K | -12.83K | -26.75K | -25.37K | |
| Working capital | 627.09B | 699.25B | 648.26B | 975.93B | 1003.86B | |
| Tangible asset value | 2044.05B | 2156.99B | 2063.92B | 0 | 0 | |
| Net current asset value | -256.03B | -199.48B | -384.15B | -334.8B | -302.52B | |
| Invested capital | 0.76 | 0.68 | 0.74 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 32.47 | 32.47 | 31.28 | 0 | 0 | |
| Days of inventory on hand | 63.2 | 65.44 | 68.65 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.77 | 2.77 | 2.88 | 0 | 0 | |
| Inventory turnover | 1.42 | 1.38 | 1.31 | 0 | 0 | |
| ROE | 0.04 | 0.04 | 0.01 | 0.02 | 0.02 | |
| Capex per share | -6.79K | -5K | -624.97 | -613.39 | -455.93 |
Frequently Asked Questions
What is Samyang Holdings Corporation stock symbol ?
Samyang Holdings Corporation is a US stock and trading under the symbol 000075.KS
What is Samyang Holdings Corporation stock quote today ?
Samyang Holdings Corporation stock price is $58900 today.
Is Samyang Holdings Corporation stock public?
Yes, Samyang Holdings Corporation is a publicly traded company.
Company Profile
- Volume Average 56
- Market Capitalization 481.88B
- Employee 449
- Headquarters Seoul,US
- IPO Date 2005-09-29
-
Website
https://www.samyang.com 
Samyang Holdings Corporation, together its subsidiaries, engages in chemical, food, packaging, pharmaceutical, and other businesses in South Korea. It produces and sells value-added materials, terephthalic acid, polycarbonate (PC) resins, bisphenol-A, engineering plastics, PC and polybutylene terephtalate compounds, PET bottles, and long fiber reinforced thermoplastics. It offers health and wellness products, and starch sugar; and operates a salad & brunch concept restaurant under the Seven Springs name, as well as a bakery under the Café Seven Springs name. In addition, the company develops and sells anti-cancer drugs, such as Genexol and Nanoxel PM; NicoStop, a smoking cessation patch; and biodegradable sutures, including Trisorb and Monosorb, as well as exports its products to 80 countries. Further, it provides IT services comprising IT consulting on system management and integration, and e-business services, as well as solutions in ERP, e-HR, MES, and mobile services to the public, finance, and manufacturing sectors. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.
